Identification of ghrelin receptor blocker, D-[Lys3] GHRP-6 as a CXCR4 receptor antagonist

International Journal of Biological Sciences

Volumn 8, Issue 1, 2011, Pages 108-117

  Patel, Kalpesh ^a,b   Dixit, Vishwa Deep ^a,c   Lee, Jun Ho ^a   Kim, Jie Wan ^a   Schaffer, Eric M ^a,d   Nguyen, Dzung ^a,e   Taub, Dennis D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

^e BIOLEGEND   (United States)

Author keywords

Cancer; CXCL12; CXCR4; Ghrelin; GHRP 6; GHS R1a; HIV 1; Inflammation

Indexed keywords

EID: 83655181798     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.8.108     Document Type: Article

References (26)

1. Miyasaka M, Tanaka T: Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004, 4:360-370.
2. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540-550.
3. Campbell DJ, Kim CH, Butcher EC: Chemokines in the systemic organization of immunity. Immunol Rev 2003, 195:58-71.
4. Cascieri MA, Springer MS: The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr Opin Chem Biol 2000, 4:420-427.
5. Castagna A, Biswas P, Beretta A, Lazzarin A: The appealing story of HIV entry inhibitors: from discovery of biological mechanisms to drug development. Drugs 2005, 65:879-904.
6. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA: A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 2003, 100:13513-13518.
7. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, et al: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
8. Kojima M, Kangawa K: Ghrelin: structure and function. Physiol Rev 2005, 85:495-522.
9. Smith RG: Development of growth hormone secretagogues. Endocr Rev 2005, 26:346-360.
10. Taub DD: Novel Connections between the Neuroendocrine and Immune Systems: The Ghrelin Immunoregulatory Network. Vit Horm 2008, 77: 325-346.
11. Redelman D, Welniak L, Taub DD, Murphy WJ: Neuroendo-crine hormones such as growth hormone (GH) and prolactin (PRL) are integral members of the immunological cytokine network. Cell Immunol 2008, 252(1-2):111-121.
12. Patel K, Taub DD: Role of neuropeptides, hormones, and growth factors in regulating thymopoiesis in middle to old age. F1000 Biology Reports 2009, 1:42.
13. Taub DD, Murphy WJ, Longo DL: Rejuvenation of the Aging Thymus: GH- and Ghrelin-Signaling Pathways. Curr Opin Pharm 2010, 10(4):408-424.
14. Morner A, Bjorndal A, Albert J, Kewalramani VN, Littman DR, Inoue R, Thorstensson R, Fenyo EM, Bjorling E: Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 1999, 73:2343-2349.
15. Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, Redpath E, Bridger G, Henson GW: Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 2000, 44:1667-1673.
16. Popovic M, Read-Connole E, Gallo RC: T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III. Lancet 1984, 2:1472-1473.
17. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW, Jr., Taub DD: Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004, 114:57-66.
18. Nguyen DH, Taub D: CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol 2002, 168: 4121-4126.
19. De Clercq E: The bicyclam AMD3100 story. Nat Rev Drug Discov 2003, 2:581-587.
20. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004, 64:8604-8612.
21. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A, Allavena P: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 2004, 64:8420-8427.
22. Lenoir M, Djerdjouri B, Perianin A: Stroma cell-derived factor 1alpha mediates desensitization of human neutrophil respiratory burst in synovial fluid from rheumatoid arthritic patients. J Immunol 2004, 172:7136-7143.
23. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, Liles WC, Li X, Graham-Evans B, Campbell TB, et al: Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005, 201:1307-1318.
24. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M: Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52:947-952.
25. Kino T, Chrousos GP: AIDS-related insulin resistance and lipodystrophy syndrome. Curr Drug Targets Immune Endocr Metabol Disord 2003, 3:111-117.
26. Choi WT, Tian S, Dong CZ, Kumar S, Liu D, Madani N, An J, Sodroski JG, Huang Z: Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors. J Virol 2005, 79:15398-15404.